Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 692-448-4 | CAS number: 170621-28-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation (OECD 429): not sensitising
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 Feb - 06 Mar 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP - Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hess. Ministerium für Umwelt, Energie, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V., AD Horst, The Netherlands
- Age at study initiation: 10-11 weeks (pre-test); 8-9 weeks (main study)
- Weight at study initiation: 20.7 g (animals of the range-finding test) and 20.2 g (animals of the main study)
- Housing: animals were housed in Makrolon Type II (pre-test)/III (main study) with wire mesh top (EHRET GmbH, Emmendingen, Germany) and granulated soft wood bedding (Rettenmaier & Söhne GmbH + Co. KG, Rosenberg, Germany).
- Diet: pelleted standard diet (Harlan Laboratories B.V., AD Horst, Netherlands), ad libitum
- Water: tap water (Gemeindewerke, Rossdorf, Germany), ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 32-65 (acclimation period); 45-65 (pre-test and main study)
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- propylene glycol
- Concentration:
- 5, 10, and 25% (w/v)
- No. of animals per dose:
- Range-finding test: 1 (in test groups)
Main study: 4 (controls), 4 (in test groups) - Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: the compound solubility was determined according to the recommendations given in OECD guideline 429. The highest test item concentration, which could be technically used, was a 25% suspension in propylene glycol. At higher concentrations, an applicable formulation of the test item was not achieved, neither by the use of other vehicles nor by using additional methods to formulate the test item (e.g. sonication, warming to 37 °C).
- Irritation: to determine the highest non-irritant test concentration that at the same time did not induce signs of systemic toxicity, two mice were treated once daily on three consecutive days with concentrations of 10% and 25% by topical (epidermal) application to the dorsal surface of each ear. Clinical signs were recorded at least once daily. Signs of local skin irritation were documented and a score was used to grade a possible erythema of the ear skin. Prior to the first application of the test item (on Day 1), on Day 3 and before sacrifice (on Day 6) the ear thickness was determined using a micrometer (S0247 Kroeplin, Schlüchtern, Germany). Ear irritation was considered to be excessive if an erythema of the ear skin of a score value ≥ 3 was observed at any observation time and/or if an increase in ear thickness of ≥ 25% was recorded on Day 3 or Day 6. At the tested concentrations, the animals did not show any signs of local skin irritation or systemic toxicity. Based on these results, concentrations selected for the main study were 5, 10 and 25% (w/w).
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: ³H-methyl thymidine (³HTdR) incorporation determined by β-scintillation
- Criteria used to consider a positive response: the test substance was considered a skin sensitiser in the LLNA if the following criteria were met:
(1) the exposure to at least one concentration of the test substance resulted in an incorporation of ³HTdR at least 3-fold greater than in controls (as indicated by the stimulation index) and
(2) the data were compatible with a conventional dose response, although allowance had to be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION: each animal was treated by topical application of 25 μL of the different test substance concentrations and the respective vehicle (propylene glycol as vehicle control) on the entire dorsal surface of each ear. The application was repeated on Days 2 and 3. On Day 6, each animal was treated with 250 μL of 80.4 μCi/mL ³HTdR (corresponds to 20.1 µCi ³HTdR per mouse) in phosphate buffered saline (PBS) by intravenous injection via the tail vein. After five hours, mice were euthanised by intraperitoneal injection of sodium pentobarbital and the draining auricular lymph nodes were rapidly excised. The nodes of each animal were pooled (8 nodes per group) and single cell suspensions (SCS) in PBS were prepared by gentle mechanical disaggregation of each pooled lymph node cells (LNCs) through stainless steel gauze (200 µm mesh size). LNCs were pelleted by centrifugation, and washed twice with PBS. After removal of the washing solution, pellets were resuspended in 5% trichloroacetic acid and incubated at 4 °C for approximately 18 h for precipitation of macromolecules. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Mean values and standard deviations of body weights and DPM values were calculated. Statistical analysis of the mean DPM values was performed between treated and control groups to assess a dose-response relationship.
- Positive control results:
- A significant increase in the stimulation indices (SI ≥ 3) was noted for the positive control substance hexyl cinnamic aldehyde in acetone:olive oil (4+1) at a concentration of 25% (SI = 5.9)
- Key result
- Parameter:
- SI
- Value:
- 1.03
- Test group / Remarks:
- 5% test substance
- Key result
- Parameter:
- SI
- Value:
- 0.58
- Test group / Remarks:
- 10% test substance
- Key result
- Parameter:
- SI
- Value:
- 0.68
- Test group / Remarks:
- 25% test substance
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- The lymph nodes of each group were pooled and group DPM values were measured from the pooled lymph node cell suspensions. The measured group DPM values were corrected by subtracting the background DPM value (average of the two measured DPM values of 5% (w/v) trichloroacetic acid solutions). Treatment with 5, 10 and 25% (w/v) test substance in propylene glycol resulted in group DPM/lymph node of 250.1, 139.9 and 165.4, respectively (see Table 1 under "Any other information on results incl. table"). The DPM/lymph node value for the control group was 241.8.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- CLP: not classified
Reference
No symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.
Table 1. Calculation of group DPM and SI values.
Test item concentration % (w/v) |
Group |
Measurement DPM |
Calculation |
Result |
||
DPM-BG* |
Number of lymph nodes |
DPM per lymph node** |
SI |
|||
- |
BG I |
19 |
- |
- |
- |
- |
- |
BG II |
20 |
- |
- |
- |
- |
0 |
1 |
1954 |
1935 |
8 |
241.8 |
1.00 |
5 |
2 |
2020 |
2001 |
8 |
250.1 |
1.03 |
10 |
3 |
1139 |
1120 |
8 |
139.9 |
0.58 |
25 |
4 |
1343 |
1324 |
8 |
165.4 |
0.68 |
BG = background (1 mL 5% trichloroacetic acid)
1 = control group; 2-4: test groups
SI = stimulation index relative to the mean of the control group (group 1)
* values corrected for mean background value (BG I and BG II)
** Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The skin sensitising potential of aluminium magnesium vanadium oxide was investigated in a Local Lymph Node Assay (LLNA) in mice according to OECD guideline 429 and in compliance with GLP (2012). Based on a range-finding test in two female CBA/CaOlaHsd mice, test substance concentrations of 5, 10, and 25% (w/v) in propylene glycol were selected for the treatment of mice in the main study. In this experiment, 4 female CBA/CaOlaHsd mice per test group were treated with the diluted test substance or vehicle alone, respectively. The test substance formulations or the vehicle were applied on the external surface of each ear (25 µL/ear) for three consecutive days. Five days after the first topical application, the cell proliferation of pooled lymph nodes per group was measured by incorporation of ³H-methyl thymidine and expressed as the amount of radioactive disintegration per minute (DPM). The DPM/lymph node for each test group was 250.1, 139.9 and 165.4 at concentrations of 5, 10, and 25% (w/v) of the test substance, respectively. For the control group, a DPM/lymph node of 241.8 was calculated. Based on these results, stimulation indices of 1.03, 0.58 and 0.68 were calculated for treatment concentrations of 5, 10, and 25% (w/v), respectively. No local or systemic toxicity and no effects on body weights were observed. The historical positive control hexyl cinnamic aldehyde confirmed the sensitivity and reliability of the experimental technique (SI ≥ 3). Under the above mentioned conditions, aluminium magnesium vanadium oxide was not found to be a sensitiser in the LLNA.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available data on the skin sensitising potential of aluminium magnesium vanadium oxide do not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.